Atlas Trials

Efficacy and Safety Study of Bendamustine With or Without Rituximab in Chronic Lymphoproliferative Disorders

Clinical trial NCT01832597 · COMPLETED

Trial details

NCT number
NCT01832597
Sponsor
Gruppo Italiano Studio Linfomi
Status
COMPLETED
Study type
OBSERVATIONAL
Chronic Lymphocytic Leukaemia
Start date
2010-11-01
Primary completion
2010-12-01
Enrollment
109

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.